Lang AE - Search Results

1

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.

Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators. Ravina B, et al. Among authors: lang ae. Mov Disord. 2009 Oct 30;24(14):2081-90. doi: 10.1002/mds.22690. Mov Disord. 2009. PMID: 19691116

2

What is it? Case 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girl.

Russman BS, Lang AE, Fahn S, Greene P, Grunnet ML. Russman BS, et al. Among authors: lang ae. Mov Disord. 1992 Oct;7(4):373-9. doi: 10.1002/mds.870070415. Mov Disord. 1992. PMID: 1336568 No abstract available.

3

What is it? Case 1, 1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb.

Greene PE, Fahn S, Lang AE, Watts RL, Eidelberg D, Powers JM. Greene PE, et al. Among authors: lang ae. Mov Disord. 1990;5(4):341-51. doi: 10.1002/mds.870050420. Mov Disord. 1990. PMID: 2259362 No abstract available.

4

What is it? Case 1, 1987: unusual tremors, bradykinesia, and cerebral lucencies.

Shale H, Fahn S, Koller WC, Lang AE. Shale H, et al. Among authors: lang ae. Mov Disord. 1987;2(4):321-38. doi: 10.1002/mds.870020411. Mov Disord. 1987. PMID: 3504559 No abstract available.

5

Psychogenic parkinsonism.

Lang AE, Koller WC, Fahn S. Lang AE, et al. Arch Neurol. 1995 Aug;52(8):802-10. doi: 10.1001/archneur.1995.00540320078015. Arch Neurol. 1995. PMID: 7639632

6

Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.

McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW, et al. McDermott MP, et al. Among authors: lang ae. Arch Neurol. 1995 Jun;52(6):565-70. doi: 10.1001/archneur.1995.00540300037010. Arch Neurol. 1995. PMID: 7763203 Clinical Trial.

7

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

Goetz CG, Stebbins GT, Shale HM, Lang AE, Chernik DA, Chmura TA, Ahlskog JE, Dorflinger EE. Goetz CG, et al. Among authors: lang ae. Mov Disord. 1994 Jul;9(4):390-4. doi: 10.1002/mds.870090403. Mov Disord. 1994. PMID: 7969204 Clinical Trial.

8

The role of surgery in Parkinson's disease management.

Olanow CW, Marsden CD, Lang AE, Goetz CG. Olanow CW, et al. Among authors: lang ae. Neurology. 1994 Mar;44(3 Suppl 1):S17-20. Neurology. 1994. PMID: 8121577 No abstract available.

9

Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.

Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE. Comella CL, et al. Among authors: lang ae. Mov Disord. 1997 Jul;12(4):570-5. doi: 10.1002/mds.870120414. Mov Disord. 1997. PMID: 9251076

10

Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease.

Kumar R, Lozano AM, Montgomery E, Lang AE. Kumar R, et al. Among authors: lang ae. Mov Disord. 1998;13 Suppl 1:73-82. Mov Disord. 1998. PMID: 9613722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,133 results

Search Page